Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House passes pharmacy-practice revisions authorizing limited oncology dispensing, sets study and enforcement conditions
Summary
The House approved a sixth substitute to the Pharmacy Practice Act that allows limited practitioner dispensing of oncology medications for actively treated outpatients, requires reporting and sterile-preparation standards, sets a three-year sunset, and directs DOPL enforcement and a stakeholder study.
The Utah House on March 6 approved the sixth substitute to Senate Bill 161, revising the Pharmacy Practice Act to allow narrowly defined practitioner dispensing of oncology medications for actively treated cancer outpatients while adding enforcement and oversight measures.
Representative Vickers, speaking for the bill, said the substitute permits oncologists in certain settings to dispense cancer medications and supportive drugs to patients actively receiving chemotherapy while excluding…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
